Last reviewed · How we verify
NCT03867266: FLAI
Typical Atrial Flutter, Ablation Index and Point by Point Ablation
trial testing Ablation with radiofrequency in Typical Atrial Flutter in 400 participants. Status unknown.
1 June 2019
Quick facts
| Lead sponsor | Ospedale San Francesco |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 20 February 2019 |
| Primary completion | 1 June 2019 |
| Estimated completion | 1 July 2019 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Ablation with radiofrequency
Conditions studied
- Typical Atrial Flutter — all drugs for Typical Atrial Flutter →
Sponsor
Ospedale San Francesco
Who can join
Adults 18 to 90, any sex, with Typical Atrial Flutter. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Ablation of the typical atrial flutter can be considered substantially anatomical, the investigators want to test a protocol that foresees the use a lesion index (AI) and that respects the Inter-Lesion Distance (ILD) ≤ 6 mm on the cavo-tricuspid isthmus (CTI) The investigators want to prove how the introduction of a lesion index combined with the continuity of lesion can allow a "first pass block" of the CTI decreasing total Radio-Frequency (RF) times
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03867266
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Typical Atrial Flutter
Currently open trials in the same condition.
- NCT06157437 — An Exploratory Study of Focal Pulse Ablation System in the Treatment of Atrial Arrhythmia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03867266 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ospedale San Francesco
- Last refreshed: 7 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03867266.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing